Stay updated on Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial
Sign up to get notified when there's something new on the Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial page.

Latest updates to the Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check33 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check75 days agoChange DetectedThe webpage has been updated to reflect a new clinical trial focusing on the safety of crisaborole (2%) ointment compared to betamethasone valerate (0.1%) cream for atopic dermatitis, with specific details about the study's design and collaborators. Notably, the previous aims and methodologies related to assessing safety biomarkers have been removed.SummaryDifference34%
- Check83 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
Stay in the know with updates to Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial page.